CYCLO(-HIS-PRO) manufacturers
- Cyclo(his-pro)
-
- $31.00 / 1mg
-
2024-11-19
- CAS:53109-32-3
- Min. Order:
- Purity: 99.87%
- Supply Ability: 10g
|
| | CYCLO(-HIS-PRO) Basic information |
| Product Name: | CYCLO(-HIS-PRO) | | Synonyms: | (3S,6S)-3-(3H-imidazol-4-ylmethyl)-1,4-diazabicyclo[4.4.0]decane-2,5-dione;Histidylproline diketopiperazine;histidylproline dioxopiperazine;Cyclo-Pro-His-HO;HIS-PRO, CYCLIC;CYCLO(-HIS-PRO);Cyclo(histidyl-proline);CYCLO(HISTIDYL-PROLINE); HISTIDYLPROLINE DIKETOPIPERAZINE | | CAS: | 53109-32-3 | | MF: | C11H14N4O2 | | MW: | 234.25 | | EINECS: | | | Product Categories: | | | Mol File: | 53109-32-3.mol |  |
| | CYCLO(-HIS-PRO) Chemical Properties |
| Melting point | 162-164 °C | | Boiling point | 659.3±48.0 °C(Predicted) | | density | 1.41±0.1 g/cm3(Predicted) | | storage temp. | 2-8°C | | solubility | DMF: 1 mg/ml; DMSO: 1 mg/ml; Ethanol: 1 mg/ml; PBS (pH 7.2): 1 mg/ml | | form | A neat oil | | pka | 12.73±0.40(Predicted) | | color | Light yellow to yellow |
| | CYCLO(-HIS-PRO) Usage And Synthesis |
| Uses | Cyclo(L-histidyl-L-proline) is used in the pharmaceutical composition comprising cyclo(His-Pro) for preventing or treating obesity. | | Definition | ChEBI: Cyclo(L-His-L-Pro) is a homodetic cyclic peptide resulting from the formal condensation of both the amino and acid groups of L-histidine with the acid and amino groups of L-proline. It is a metabolite of thyrotropin-releasing hormone (TRH). It has a role as a human blood serum metabolite, a dopamine uptake inhibitor and an anti-inflammatory agent. It is a homodetic cyclic peptide, a dipeptide, a pyrrolopyrazine and a member of imidazoles. It is functionally related to a L-histidine and a L-proline. | | in vivo | Cyclo(his-pro) (Cyclo(histidyl-proline); 1.8 mg/ear; topical application on the right ear; 30 min prior to TPA) reduces TPA-induced ear oedema confirming that it can exert anti-inflammatory effect[2].
Cyclo(his-pro) exerts in vivo anti-inflammatory effects in the central nervous system by down-regulating hepatic and cerebral TNFα expression thereby counteracting LPS-induced gliosis. Moreover, by up-regulating Bip, Cyclo(his-pro) increases the ER stress sensitivity andtriggers the unfolded protein response to alleviate the ER stress[3].
| Animal Model: | Sixty two/three month-old male C57BL/6 mice (25-30 g)[2] | | Dosage: | 1.8 mg/ear | | Administration: | Topical application on the right ear; 30 min prior to TPA | | Result: | Reduced TPA-induced ear oedema.
|
| | IC 50 | NF-κB; Human Endogenous Metabolite |
| | CYCLO(-HIS-PRO) Preparation Products And Raw materials |
|